Speaker Profile

PMWC PIONEER AWARD
Groundbreaking Work in Cancer Immunotherapy and the Development of T Cell Receptor (TCR) Therapies for Various Cancers

MD, Professor, Fred Hutchinson

Biography
Stanley Riddell is a physician scientist at the Fred Hutchinson Cancer Center where he has contributed to the development of genemodified cell therapies for cancer. Riddell trained in medical oncology and joined the faculty at the Fred Hutchinson Cancer Center, where he established his research program. Throughout his career, Riddell has been a pioneer in the field of genemodified cell therapies, particularly CART cells. His research has focused on genetically modifying T cells to attack cancer, which has shown remarkable promise in treating leukemia and lymphoma. Riddell has also made significant contributions to the field of stem cell transplantation where he developed innovative strategies to reduce graftversushost disease. Riddell's research has earned him numerous awards and honors. He is a recipient a Research Professor of the American Cancer Society, the International Society for Biological Therapy Team Science Award, and a Hans Fischer Senior Fellow Award at the Technical University of Munich.


 Session Abstract – PMWC 2024 Silicon Valley

Track 1 - January 25 9.00 A.M.-4.30 P.M.


Track Chair: Sharon Benzeno, Adaptive Biotechnologies

  • PMWC 2024 Award Ceremony
    Pioneer Honoree: Stanley Riddell, Fred Hutchinson
    Pioneer Honoree: George Coukos, Ludwig Cancer Center
  • Keynote: Engineering Synthetic T Cell States for Cancer Rejection
    - George Coukos, Ludwig Cancer Center
  • Discovery of Novel Targets in Cell Therapies in Oncology and Autoimmune Disorders (PANEL)
    Chair: Harlan Robins, Adaptive Bio
    - Stanley Riddell, Fred Hutchinson
    - Allison Betof Warner, Stanford
    - Lawrence Fong, UCSF
  • Supply Chain 2.0 Getting Cell Therapies to Patients (PANEL)
    Chair: Jean Xu, Janssen Pharmaceuticals
    - Amanda Pace, Sonoma Bio
    - Laura Deschenes, Sana Biotechnology
  • Evolving Case Law and Practical Strategies for Immunotherapy Patents
    - Janet Xiao, Morrison & Foerster LLP
  • Emerging Clinical Data in Oncology Cell Therapeutics
    Chair: Andrew Allen, Gritstone bio, Inc.
    - Robert Meehan, Moderna
  • Scientific Advancements in Individualized Cell Therapies in Oncology ( PANEL)
    Chair: Sharon Benzeno, Adaptive Biotechnologies
    - Ira Mellman, Genenetch
    - Robert Meehan, Moderna
    - Dirk Nagorsen, Affini-T Therapeutics
  • AI-Enhanced Approaches in Cell Therapy Development
    Chair: Suchit Jhunjhunwala, Genentech
    - Brian Weitzner, Outpace Bio
  • PMWC Showcase
    - Arun Wiita, UCSF

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by APR. 25TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required